CAS 121808-62-6
:Pidotimod
Description:
Pidotimod is a synthetic immunomodulatory agent primarily used in the treatment of recurrent respiratory infections, particularly in children. It is characterized by its ability to enhance the immune response, particularly by stimulating the activity of T lymphocytes and promoting the production of cytokines. Pidotimod is known for its low toxicity and favorable safety profile, making it suitable for long-term use. The substance is typically administered orally and is well-absorbed in the gastrointestinal tract. Its mechanism of action involves modulating both innate and adaptive immunity, which helps in improving the body's defense against pathogens. Pidotimod has also been studied for its potential benefits in various allergic and autoimmune conditions. As a chemical entity, it is classified as a small molecule with a specific molecular structure that contributes to its biological activity. Overall, pidotimod represents a valuable therapeutic option in enhancing immune function and reducing the frequency of infections.
Formula:C9H12N2O4S
InChI:InChI=1S/C9H12N2O4S/c12-7-2-1-5(10-7)8(13)11-4-16-3-6(11)9(14)15/h5-6H,1-4H2,(H,10,12)(H,14,15)/t5-,6-/m0/s1
InChI key:InChIKey=UUTKICFRNVKFRG-WDSKDSINSA-N
SMILES:C(=O)(N1[C@H](C(O)=O)CSC1)[C@H]2NC(=O)CC2
Synonyms:- (4R)-3-[[(2S)-5-Oxo-2-pyrrolidinyl]carbonyl]-4-Thiazolidinecarboxylic acid
- 4-Thiazolidinecarboxylic acid, 3-[(5-oxo-2-pyrrolidinyl)carbonyl]-, [R-(R*,S*)]-
- 4-Thiazolidinecarboxylic acid, 3-[[(2S)-5-oxo-2-pyrrolidinyl]carbonyl]-, (4R)-
- Adimod
- Axil (pharmaceutical)
- Onaka
- Pidotimond
- Pigitil
- Polimod
- Pidotimod
Sort by
Purity (%)
0
100
|
0
|
50
|
90
|
95
|
100
Found 11 products.
(4R)-3-{[(2S)-5-oxopyrrolidin-2-yl]carbonyl}-1,3-thiazolidine-4-carboxylic acid
CAS:Formula:C9H12N2O4SPurity:98%Color and Shape:SolidMolecular weight:244.2676Pidotimod
CAS:<p>Pidotimod is a synthetic dipeptide with immunomodulatory properties.</p>Formula:C9H12N2O4SPurity:97.56% - 99.74%Color and Shape:Almost White To White Crystalline PowderMolecular weight:244.27(R)-3-((S)-5-Oxopyrrolidine-2-Carbonyl)Thiazolidine-4-Carboxylic Acid
CAS:<p>(R)-3-((S)-5-Oxopyrrolidine-2-Carbonyl)Thiazolidine-4-Carboxylic Acid</p>Purity:98%Molecular weight:244.27g/molPidotimod
CAS:Formula:C9H12N2O4SPurity:>98.0%(T)(HPLC)Color and Shape:White to Almost white powder to crystalMolecular weight:244.27Pidotimod
CAS:Controlled Product<p>Applications Immunostimulant used in patients with cell-mediated immunodepression.<br>References Gu, C., et al.: Pharm. Res., 25, 979 (2008), Fliri, A., et al.: J. Med. Chem., 52, 8038 (2009), Giagulli, C., et al.: Int. Immunopharmacol., 9, 1366 (2009),<br></p>Formula:C9H12N2O4SColor and Shape:NeatMolecular weight:244.27Pidotimod
CAS:<p>Pidotimod is a small molecule (dipeptide) that acts as immunomodulator. It activates the immune system by binding to Toll-like receptor (TLR) 4 and TLR2 and it is involved in the regulation of TLRs signaling pathways. Pidotimod has chemokine activity on CXC chemokine receptor 3 (CXCR3) that triggers monocyte adhesion and migration by activation of tyrosine phosphorylation-based cell signaling. Recent studies showed that pidotimod can be used to treat acute respiratory tract infections (RTIs) and its pharmacokinetic studies has shown its ability to boost the immunoresponse and favouring the increase in the level of immunoglobulins (IgA, IgM, IgG) and T-lymphocytes (CD3+, CD4+). Pidotimod also exhibits anti-inflammatory properties by inhibiting the production of pro-inflammatory molecules such as IL-6 and TNF-α, which are linked to autoimmune diseases</p>Formula:C9H12N2O4SPurity:Min 98%Color and Shape:White PowderMolecular weight:244.27 g/molPidotimod - Bio-X ™
CAS:<p>Pidotimod is a small molecule (dipeptide) that acts as immunomodulator. It activates the immune system by binding to Toll-like receptor (TLR) 4 and TLR2 and it is involved in the regulation of TLRs signaling pathways. Pidotimod has chemokine activity on CXC chemokine receptor 3 (CXCR3) that triggers monocyte adhesion and migration by activation of tyrosine phosphorylation-based cell signaling. Recent studies showed that pidotimod can be used to treat acute respiratory tract infections (RTIs) and its pharmacokinetic studies has shown its ability to boost the immunoresponse and favouring the increase in the level of immunoglobulins (IgA, IgM, IgG) and T-lymphocytes (CD3+, CD4+). Pidotimod also exhibits anti-inflammatory properties by inhibiting the production of pro-inflammatory molecules such as IL-6 and TNF-α, which are linked to autoimmune diseases.</p>Formula:C9H12N2O4SColor and Shape:PowderMolecular weight:244.27 g/mol(R)-3-((S)-5-Oxopyrrolidine-2-carbonyl)thiazolidine-4-carboxylic acid
CAS:Formula:C9H12N2O4SPurity:98%Color and Shape:SolidMolecular weight:244.27








